Lengo Therapeutics

Blueprint Medicines Corporation  a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced that, effective on…

Summary : – Expands Blueprint Medicines’ lung cancer pipeline with LNG-451, a highly selective brain-penetrant precision therapy targeting EGFR exon 20 insertion…